Skip to main content
Equibles
VMD logo

VMD · Viemed Healthcare, Inc. · Webcasts, Transcripts & Audio

Track VMD — free

Use VMD with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research VMD.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$9.24 +0.11 (+1.20%) At close · Oct 5
Russell 2000 member Rebalance outlook locked
Market Cap
$339.37M
Shares
38.09M
Volume · Oct 5 217.81K Avg daily vol (3M) 354.16K

Viemed Healthcare, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Viemed Healthcare, Inc. (VMD), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▲22.1% $35.76M $1.05M '22 Q3 22-11-01 ▲17.4% $37.51M $2.44M '22 Q4 23-03-02 ▲22.6% $39.56M $1.52M '23 Q1 23-05-08 ▲30% $43.31M $2.33M '23 Q2 23-08-09 ▲38.2% $49.40M $2.92M '23 Q3 23-11-01 ▲35.3% $50.74M $3.48M '23 Q4 24-03-06 ▲27.9% $50.59M $1.60M '24 Q1 24-05-06 ▲26.9% $54.97M $1.47M '24 Q2 24-08-07 ▲17.4% $58.00M $3.88M '24 Q3 24-11-06 ▲19.6% $60.70M $4.32M '24 Q4 25-03-10 ▲16.9% $59.13M $2.62M '25 Q1 25-05-07 ▲14.7% $63.06M $3.16M '25 Q2 25-08-06 ▲24% $71.91M $3.51M '25 Q3 25-11-05 ▲25.5% $76.18M $5.64M '25 Q4 26-03-05 ▲27.5% $75.41M $2.58M '26 Q1 26-05-06 LATEST ▲23.9% $78.10M $2.76M '26 Q2 26-08-04
Earnings call
FY26 · Q2
2026-08-04
Viemed Healthcare, Inc. (VMD) Q2 2026 Earnings Call Transcript
Confident tone Ventilation growth under new CMS NCD framework Compliance and clinical engagement Maternal health / LeeHand integration
Revenue
$78.10M
▲ 23.9% YoY
Diluted EPS
$0.07
▼ 12.5% YoY
Gross margin
57.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-05-06
Viemed Healthcare, Inc. (VMD) Q1 2026 Earnings Call Transcript
Confident tone Ventilation NCD dynamics Sleep / PAP therapy growth Financial performance and free cash flow
Revenue
$75.41M
▲ 27.5% YoY
Diluted EPS
$0.06
▲ 0% YoY
Gross margin
56.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2026-03-05
Viemed Healthcare, Inc. (VMD) Q4 2025 Earnings Call Transcript
Confident tone NCD transition and ventilators Sleep and resupply growth Regulatory environment and competitive bidding
Revenue
$76.18M*
▲ 25.5% YoY
Gross margin
57.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-11-05
Viemed Healthcare, Inc. (VMD) Q3 2025 Earnings Call Transcript
Confident tone Sleep Therapy and Resupply Growth Lehan's Medical Equipment Acquisition and Integration Respiratory/Ventilation Core Business
Revenue
$71.91M
▲ 24% YoY
Diluted EPS
$0.09
▼ 10% YoY
Gross margin
57.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-08-06
Viemed Healthcare, Inc. (VMD) Q2 2025 Earnings Call Transcript
Confident tone Competitive bidding risk Core ventilation growth Capital allocation and margins
Revenue
$63.06M
▲ 14.7% YoY
Diluted EPS
$0.08
▲ 100% YoY
Gross margin
58.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-05-07
Viemed Healthcare, Inc. (VMD) Q1 2025 Earnings Call Transcript
Confident tone Regulatory and Reimbursement Environment Lehan's Medical Equipment Acquisition First Quarter Operational Performance
Revenue
$59.13M
▲ 16.9% YoY
Diluted EPS
$0.06
▲ 50% YoY
Gross margin
56.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2025-03-10
Viemed Healthcare, Inc. (VMD) Q4 2024 Earnings Call Transcript
Confident tone Behavioral health opportunity Cash flow outlook In-home care trend
Revenue
$60.70M*
▲ 19.6% YoY
Gross margin
59.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-11-06
Viemed Healthcare, Inc. (VMD) Q3 2024 Earnings Call Transcript
Confident tone Core vent business growth Philips ventilator recall replacement / CapEx Sleep business and GLP-1 impact
Revenue
$58.00M
▲ 17.4% YoY
Diluted EPS
$0.10
▲ 42.9% YoY
Gross margin
59.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-08-07
Viemed Healthcare, Inc. (VMD) Q2 2024 Earnings Call Transcript
Confident tone Philips ventilator buyback and fleet refresh Organic revenue growth and core ventilator business Sleep / CPAP business and GLP-1 dynamics
Revenue
$54.97M
▲ 26.9% YoY
Diluted EPS
$0.04
▼ 33.3% YoY
Gross margin
59.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Viemed Healthcare, Inc. (VMD) Q1 2024 Earnings Call Transcript
Confident tone Sleep Apnea Market Growth Change Healthcare Disruption Hospital Joint Ventures and HMP Integration
Revenue
$50.59M
▲ 27.9% YoY
Diluted EPS
$0.04
▲ 0% YoY
Gross margin
58.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-06
Viemed Healthcare, Inc. (VMD) Q4 2023 Earnings Call Transcript
Confident tone CMS final rules on managed care HMP acquisition and inorganic growth Regulatory and reimbursement environment
Revenue
$50.74M*
▲ 35.3% YoY
Gross margin
63.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-01
Viemed Healthcare, Inc. (VMD) Q3 2023 Earnings Call Transcript
Revenue
$49.40M
▲ 38.2% YoY
Diluted EPS
$0.07
▲ 133.3% YoY
Gross margin
61.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-09
Viemed Healthcare, Inc. (VMD) Q2 2023 Earnings Call Transcript
Revenue
$43.31M
▲ 30% YoY
Diluted EPS
$0.06
▲ 200% YoY
Gross margin
60.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-08
Viemed Healthcare, Inc. (VMD) Q1 2023 Earnings Call Transcript
Revenue
$39.56M
▲ 22.6% YoY
Diluted EPS
$0.04
▲ 0% YoY
Gross margin
60.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-02
Viemed Healthcare, Inc. (VMD) Q4 2022 Earnings Call Transcript
Revenue
$37.51M*
▲ 17.4% YoY
Gross margin
61.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Viemed Healthcare, Inc. (VMD) Q3 2022 Earnings Call Transcript
Revenue
$35.76M
▲ 22.1% YoY
Diluted EPS
$0.03
▼ 25% YoY
Gross margin
60.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Viemed Healthcare, Inc. (VMD) Q2 2022 Earnings Call Transcript
Revenue
$33.31M
▲ 21.6% YoY
Diluted EPS
$0.02
▼ 50% YoY
Gross margin
61.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-05-04
Viemed Healthcare, Inc. (VMD) Q4 2021 Earnings Call Transcript
Revenue
$31.96M*
▲ 2.4% YoY
Gross margin
61.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q1
2022-05-03
Viemed Healthcare, Inc. (VMD) Q1 2022 Earnings Call Transcript
Revenue
$32.26M
▲ 13.5% YoY
Diluted EPS
$0.04
▲ 0% YoY
Gross margin
61.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q3
2021-11-02
Viemed Healthcare, Inc. (VMD) Q3 2021 Earnings Call Transcript
Revenue
$29.29M
▼ 12.4% YoY
Diluted EPS
$0.04
▼ 42.9% YoY
Gross margin
62.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-02
Viemed Healthcare, Inc. (VMD) Q2 2021 Earnings Call Transcript
Revenue
$27.40M
▼ 36.1% YoY
Diluted EPS
$0.04
▼ 91.7% YoY
Gross margin
64.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-03
Viemed Healthcare, Inc. (VMD) Q1 2021 Earnings Call Transcript
Revenue
$28.42M
▲ 19.4% YoY
Diluted EPS
$0.04
▼ 63.6% YoY
Gross margin
62.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-03
Viemed Healthcare, Inc. (VMD) Q4 2020 Earnings Call Transcript
Revenue
$31.20M
▲ 45.5% YoY
Diluted EPS
$0.12
▲ 100% YoY
Gross margin
61.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Viemed Healthcare, Inc. (VMD) Q3 2020 Earnings Call Transcript
Revenue
$33.45M
▲ 64.2% YoY
Diluted EPS
$0.07
▲ 0% YoY
Gross margin
58.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-08-05
Viemed Healthcare, Inc. (VMD) Q2 2020 Earnings Call Transcript
Revenue
$42.85M
▲ 110.8% YoY
Diluted EPS
$0.48
▲ 1500% YoY
Gross margin
60.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-04
Viemed Healthcare, Inc. (VMD) Q1 2020 Earnings Call Transcript
Revenue
$23.81M
▲ 31.4% YoY
Diluted EPS
$0.11
▲ 120% YoY
Gross margin
65.3%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-03-03
Viemed Healthcare, Inc. (VMD) Q4 2019 Earnings Call
Revenue
$21.45M
▲ 16.8% YoY
Diluted EPS
$0.06
▼ 14.3% YoY
Gross margin
66.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Showing 1–27 of 27 webcasts
Key facts CIK 1729149 CUSIP 92663R105 13F (30d) 4 filings 4 filers Visit website Investor relations